Trilinolein reduces infarct size and suppresses ventricular arrhythmias in rats subjected to coronary ligation

P. Chan, S. K. Tsai, B. N. Chiang, C. Y. Hong

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Trilinolein, a triacylglycerol with linoleic acid as the only fatty acid residue in all esterified positions of glycerol, was previously found to improve erythrocyte deformability in vitro. In this study, the in vivo antiarrhythmic and anti-ischemic effects of trilinolein in coronary ligated rats were investigated. Male Sprague-Dawley rats were anesthetized with urethane. Trilinolein, at dosages ranging from 10-11 to 10-7 g/kg, was administered intravenously 15 min before ligation of coronary artery. Also, the effect of trilinolein on arrhythmia was studied by ligating the coronary artery for 30 min, then reperfusing myocardium for 10 min. During the 30-min ischemia, trilinolein reduced not only the number of ectopic beats but also the incidence rate and duration of ventricular tachycardia. At 10-7 g/kg, trilinolein completely suppressed all ventricular arrhythmias. Ventricular arrhythmias during 10 min reperfusion were also reduced by trilinolein at similar dosages. Furthermore, the effect of trilinolein on infarct size was evaluated by occluding the coronary artery for 4 h before the infarct zone was stained and weighed. In rats subjected to 4h coronary ligation, pretreatment with 10-7 g/kg trilinolein at 15 min prior to the coronary ligation significantly reduced infarct size. Trilinolein may protect myocardium against ischemic injury and suppress arrhythmia during ischemia and reperfusion.

Original languageEnglish
Pages (from-to)118-126
Number of pages9
JournalPharmacology
Volume51
Issue number2
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Ligation
Cardiac Arrhythmias
Coronary Vessels
Reperfusion
Myocardium
Ischemia
trilinolein
Erythrocyte Deformability
Urethane
Linoleic Acid
Ventricular Tachycardia
Glycerol
Sprague Dawley Rats
Triglycerides
Fatty Acids
Incidence
Wounds and Injuries

Keywords

  • Coronary ischemia
  • Myocardial infarction
  • Reperfusion
  • Trilinolein
  • Ventricular arrhythmia

ASJC Scopus subject areas

  • Pharmacology

Cite this

Trilinolein reduces infarct size and suppresses ventricular arrhythmias in rats subjected to coronary ligation. / Chan, P.; Tsai, S. K.; Chiang, B. N.; Hong, C. Y.

In: Pharmacology, Vol. 51, No. 2, 1995, p. 118-126.

Research output: Contribution to journalArticle

Chan, P. ; Tsai, S. K. ; Chiang, B. N. ; Hong, C. Y. / Trilinolein reduces infarct size and suppresses ventricular arrhythmias in rats subjected to coronary ligation. In: Pharmacology. 1995 ; Vol. 51, No. 2. pp. 118-126.
@article{326c0c2db2a04998816e9b1dd5382c4c,
title = "Trilinolein reduces infarct size and suppresses ventricular arrhythmias in rats subjected to coronary ligation",
abstract = "Trilinolein, a triacylglycerol with linoleic acid as the only fatty acid residue in all esterified positions of glycerol, was previously found to improve erythrocyte deformability in vitro. In this study, the in vivo antiarrhythmic and anti-ischemic effects of trilinolein in coronary ligated rats were investigated. Male Sprague-Dawley rats were anesthetized with urethane. Trilinolein, at dosages ranging from 10-11 to 10-7 g/kg, was administered intravenously 15 min before ligation of coronary artery. Also, the effect of trilinolein on arrhythmia was studied by ligating the coronary artery for 30 min, then reperfusing myocardium for 10 min. During the 30-min ischemia, trilinolein reduced not only the number of ectopic beats but also the incidence rate and duration of ventricular tachycardia. At 10-7 g/kg, trilinolein completely suppressed all ventricular arrhythmias. Ventricular arrhythmias during 10 min reperfusion were also reduced by trilinolein at similar dosages. Furthermore, the effect of trilinolein on infarct size was evaluated by occluding the coronary artery for 4 h before the infarct zone was stained and weighed. In rats subjected to 4h coronary ligation, pretreatment with 10-7 g/kg trilinolein at 15 min prior to the coronary ligation significantly reduced infarct size. Trilinolein may protect myocardium against ischemic injury and suppress arrhythmia during ischemia and reperfusion.",
keywords = "Coronary ischemia, Myocardial infarction, Reperfusion, Trilinolein, Ventricular arrhythmia",
author = "P. Chan and Tsai, {S. K.} and Chiang, {B. N.} and Hong, {C. Y.}",
year = "1995",
language = "English",
volume = "51",
pages = "118--126",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Trilinolein reduces infarct size and suppresses ventricular arrhythmias in rats subjected to coronary ligation

AU - Chan, P.

AU - Tsai, S. K.

AU - Chiang, B. N.

AU - Hong, C. Y.

PY - 1995

Y1 - 1995

N2 - Trilinolein, a triacylglycerol with linoleic acid as the only fatty acid residue in all esterified positions of glycerol, was previously found to improve erythrocyte deformability in vitro. In this study, the in vivo antiarrhythmic and anti-ischemic effects of trilinolein in coronary ligated rats were investigated. Male Sprague-Dawley rats were anesthetized with urethane. Trilinolein, at dosages ranging from 10-11 to 10-7 g/kg, was administered intravenously 15 min before ligation of coronary artery. Also, the effect of trilinolein on arrhythmia was studied by ligating the coronary artery for 30 min, then reperfusing myocardium for 10 min. During the 30-min ischemia, trilinolein reduced not only the number of ectopic beats but also the incidence rate and duration of ventricular tachycardia. At 10-7 g/kg, trilinolein completely suppressed all ventricular arrhythmias. Ventricular arrhythmias during 10 min reperfusion were also reduced by trilinolein at similar dosages. Furthermore, the effect of trilinolein on infarct size was evaluated by occluding the coronary artery for 4 h before the infarct zone was stained and weighed. In rats subjected to 4h coronary ligation, pretreatment with 10-7 g/kg trilinolein at 15 min prior to the coronary ligation significantly reduced infarct size. Trilinolein may protect myocardium against ischemic injury and suppress arrhythmia during ischemia and reperfusion.

AB - Trilinolein, a triacylglycerol with linoleic acid as the only fatty acid residue in all esterified positions of glycerol, was previously found to improve erythrocyte deformability in vitro. In this study, the in vivo antiarrhythmic and anti-ischemic effects of trilinolein in coronary ligated rats were investigated. Male Sprague-Dawley rats were anesthetized with urethane. Trilinolein, at dosages ranging from 10-11 to 10-7 g/kg, was administered intravenously 15 min before ligation of coronary artery. Also, the effect of trilinolein on arrhythmia was studied by ligating the coronary artery for 30 min, then reperfusing myocardium for 10 min. During the 30-min ischemia, trilinolein reduced not only the number of ectopic beats but also the incidence rate and duration of ventricular tachycardia. At 10-7 g/kg, trilinolein completely suppressed all ventricular arrhythmias. Ventricular arrhythmias during 10 min reperfusion were also reduced by trilinolein at similar dosages. Furthermore, the effect of trilinolein on infarct size was evaluated by occluding the coronary artery for 4 h before the infarct zone was stained and weighed. In rats subjected to 4h coronary ligation, pretreatment with 10-7 g/kg trilinolein at 15 min prior to the coronary ligation significantly reduced infarct size. Trilinolein may protect myocardium against ischemic injury and suppress arrhythmia during ischemia and reperfusion.

KW - Coronary ischemia

KW - Myocardial infarction

KW - Reperfusion

KW - Trilinolein

KW - Ventricular arrhythmia

UR - http://www.scopus.com/inward/record.url?scp=0029053265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029053265&partnerID=8YFLogxK

M3 - Article

C2 - 8584572

AN - SCOPUS:0029053265

VL - 51

SP - 118

EP - 126

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 2

ER -